Nova News
NOVA TO LAUNCH FORNAX™ CLOUD
May 2021 – novaCITYNETS, a subsidiary of Nova MSC launches FORNAX ePlanCheck as a service on the FORNAX Cloud to enable customer cloud adoption to accelerate the digitalisation process of the architecture, engineering and construction (AEC) industry. FORNAX™ Cloud is the Software as a Service (SaaS) arm of its FORNAX™ ePlanCheck system. The service will provide the Qualified Persons (QPs)…
NOVA WINS JTC SINGAPORE INNOVATION CHALLENGE
Mar 2021 – Singapore’s JTC Corporation (JTC) has awarded to novaCITYNETS, a subsidiary of Nova MSC the project under JTC Innovation Challenge initiative to ease the transition for construction companies in their adoption of Building Information Model (BIM). The JTC Innovation Challenge was an initiative started in 2015 to bring industry partners and solution providers together to address challenges in…
SELENA+ ACCEPTED BY LEADING MEDICAL INSURANCE ORGANISATION IN SOUTH AFRICA
Feb 2021 – The output from SELENA+ Deep Learning System (DLS) was assessed and has been finally accepted by Discovery Health, the leading medical scheme administrator in South Africa for reimbursement under the Chronic Illness Benefit for Diabetes Mellitus. Under this scheme, beneficiaries who use SELENA+ for a diabetic retinopathy screening are entitled to reimbursement on receipt of a referral…
EYRIS WINS THE SINGAPORE SME 500 AWARD 2021
Feb 2021 – EyRIS is pleased to announce that we have been awarded the Singapore SME 500 Award 2021: ” Business Resilience amidst COVID-19 ” in recognition of Singapore’s Top 500 SMEs. The Singapore SME 500 Award 2021 recognises SMEs that have further displayed business resilience, maintaining business continuity and showcasing their ability to transform and sustain. Launched to recognise…
EYRIS SIGNS MOU WITH DIABETES SINGAPORE
Jan 2021 – An estimated 19,000 people are diagnosed with diabetes locally each year, with over 90 per cent of people having Diabetes Type 2 Mellitus (D2M). Diabetic retinopathy (DR), a result of the damage of blood vessels in the retina, is the most common microvascular complication of diabetes and the leading cause of vision loss in working-age adults worldwide….
HSC MEDICAL CENTRE TO IMPLEMENT VESALIUS AS PART OF ITS EXPANSION PLAN
Jan 2021 – HSC Medical Center (HSC), conveniently located in the heart of Kuala Lumpur, within walking distance of the iconic Petronas Twin Towers was officially opened by the Minister of Health on 18 February 2003. It is an award-winning medical centre and a one-stop advanced health screening hub for local and international visitors and patients. Apart from offering comprehensive health…
SELENA+ RECEIVES REGULATORY APPROVAL IN INDONESIA
Jan 2021 – In Indonesia, it is estimated that nearly 16 million adults to be living with type 2 diabetes. More worringly, experts estimate more than half of diabetes cases in Indonesia remain undiagnosed, especially among young people. Every is at risk of going blind. Around a third of diabetics develop some form of eye health complication and is at…
BUILDING & CONSTRUCTION AUTHORITY, SINGAPORE AWARD BIM MODEL CHECKER PROJECT TO NOVA
Dec 2020 – Singapore’s Building and Construction Authority (BCA) has awarded to novaCITYNETS, a subsidiary of Nova MSC the project to develop a BIM Model Checking System. The BIM Model Checking System is to facilitate automatic multi-disciplinary building code checking on open format IFC BIM models. The System is intended for pre-checking of designs to reduce design errors, omissions and…
EYRIS PARTNERS TOPCON HEALTHCARE SOLUTIONS TO ROLL OUT SELENA+ IN HARMONY RS FOR 18 ASIAN COUNTRIES
Singapore (9 Nov, 2020) – Topcon Healthcare Solutions Asia Pacific, the leading Japanese ophthalmic solution provider, has inked an agreement with Singapore based EyRIS Private Limited to bring EyRIS SELENA+ to Harmony’s users in 18 countries in South and South East Asia. SELENA+ is a deep learning system (DLS) that can detect 3 eye diseases – diabetic retinopathy, glaucoma suspect…
SELENA+ RECEIVES REGULATORY APPROVAL IN BRAZIL
Oct 2020 – SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil. Brazil is one of the 20 countries of the International Diabetes Federation (IDF)…
EYRIS NAMED IN “50 INNOVATIVE COMPANIES TO WATCH 2020” LIST
Oct 2020 – EyRIS was named on the list “50 INNOVATIVE COMPANIES TO WATCH 2020” compiled by The Silicon Review. The list recognizes companies that have come up with transformative innovations that deliver a fundamental shift to a new way of doing things. EyRIS stands out amongst AI companies in the healthcare sector for developing SELENA+, an AI Deep Learning…
PROF WONG TIEN YIN, EYRIS CO-FOUNDER ELECTED INTO US NATIONAL ACADEMY OF MEDICINE
Oct 2020 – Every year, the US National Academy of Medicine welcomes 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honours in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. It fills us with pride to…